A New Testing Strategy to Identify Rare Variants with Either Risk or Protective Effect on Disease
Rapid advances in sequencing technologies set the stage for the large-scale medical sequencing efforts to be performed in the near future, with the goal of assessing the importance of rare variants in complex diseases. The discovery of new disease susceptibility genes requires powerful statistical methods for rare variant analysis. The low frequency and the expected large number of such variants pose great difficulties for the analysis of these data. We propose here a robust and powerful testing strategy to study the role rare variants may play in affecting susceptibility to complex traits. The strategy is based on assessing whether rare variants in a genetic region collectively occur at significantly higher frequencies in cases compared with controls (or vice versa). A main feature of the proposed methodology is that, although it is an overall test assessing a possibly large number of rare variants simultaneously, the disease variants can be both protective and risk variants, with moderate decreases in statistical power when both types of variants are present. Using simulations, we show that this approach can be powerful under complex and general disease models, as well as in larger genetic regions where the proportion of disease susceptibility variants may be small. Comparisons with previously published tests on simulated data show that the proposed approach can have better power than the existing methods. An application to a recently published study on Type-1 Diabetes finds rare variants in gene IFIH1 to be protective against Type-1 Diabetes.
Vyšlo v časopise:
A New Testing Strategy to Identify Rare Variants with Either Risk or Protective Effect on Disease. PLoS Genet 7(2): e32767. doi:10.1371/journal.pgen.1001289
Kategorie:
Research Article
prolekare.web.journal.doi_sk:
https://doi.org/10.1371/journal.pgen.1001289
Souhrn
Rapid advances in sequencing technologies set the stage for the large-scale medical sequencing efforts to be performed in the near future, with the goal of assessing the importance of rare variants in complex diseases. The discovery of new disease susceptibility genes requires powerful statistical methods for rare variant analysis. The low frequency and the expected large number of such variants pose great difficulties for the analysis of these data. We propose here a robust and powerful testing strategy to study the role rare variants may play in affecting susceptibility to complex traits. The strategy is based on assessing whether rare variants in a genetic region collectively occur at significantly higher frequencies in cases compared with controls (or vice versa). A main feature of the proposed methodology is that, although it is an overall test assessing a possibly large number of rare variants simultaneously, the disease variants can be both protective and risk variants, with moderate decreases in statistical power when both types of variants are present. Using simulations, we show that this approach can be powerful under complex and general disease models, as well as in larger genetic regions where the proportion of disease susceptibility variants may be small. Comparisons with previously published tests on simulated data show that the proposed approach can have better power than the existing methods. An application to a recently published study on Type-1 Diabetes finds rare variants in gene IFIH1 to be protective against Type-1 Diabetes.
Zdroje
1. LanderE
KruglyakL
1995 Genetic dissection of complex traits: guidelines for interpreting and reporting linkage results. Nat Genet 11 241 247
2. McCarthyMI
AbecasisGR
CardonLR
GoldsteinDB
LittleJ
2008 Genome-wide association studies for complex traits: consensus, uncertainty and challenges. Nat Rev Genet 9 356 369
3. HindorffLA
JunkinsHA
MehtaJP
ManolioTA
A catalog of published genome-wide association studies. Available at http://www.genome.gov/26525384
4. MaherB
2008 Personal genomes: The case of the missing heritability. Nature 456 18 21
5. ManolioTA
CollinsFS
CoxNJ
GoldsteinDB
HindorffLA
2009 Finding the Missing Heritability of Complex Diseases. Nature 461 747 753
6. FearnheadNS
WildingJL
WinneyB
TonksS
BartlettS
2004 Multiple rare variants in different genes account for multifactorial inherited susceptibility to colorectal adenomas. Proc Natl Acad Sci USA 101 15992 15997
7. CohenJC
KissRS
PertsemlidisA
MarcelYL
McPhersonR
2004 Multiple rare alleles contribute to low plasma levels of HDL cholesterol. Science 305 869 872
8. FearnheadNS
WinneyB
BodmerWF
2005 Rare variant hypothesis for multifactorial inheritance: susceptibility to colorectal adenomas as a model. Cell Cycle 4 521 525
9. CohenJC
PertsemlidisA
FahmiS
EsmailS
VegaGL
2006 Multiple rare variants in NPC1L1 associated with reduced sterol absorption and plasma low-density lipoprotein levels. Proc Natl Acad Sci USA 103 1810 1815
10. JiW
FooJN
O'RoakBJ
ZhaoH
LarsonMG
2008 Rare independent mutations in renal salt handling genes contribute to blood pressure variation. Nat Genet 40 592 599
11. StefanssonH
RujescuD
CichonS
PietilŠinenOP
IngasonA
2008 Large recurrent microdeletions associated with schizophrenia. Nature 455 232 236
12. WalshT
McClellanJM
McCarthySE
AddingtonAM
PierceSB
2008 Rare structural variants disrupt multiple genes in neurodevelopmental pathways in schizophrenia. Science 320 539 543
13. WeissLA
ShenY
KornJM
ArkingDE
MillerDT
2008 Association between microdeletion and microduplication at 16p11.2 and autism. N Engl J Med 358 667 675
14. HelbigI
MeffordHC
SharpAJ
GuipponiM
FicheraM
2009 15q13.3 microdeletions increase risk of idiopathic generalized epilepsy. Nat Genet 41 160 162
15. NejentsevS
WalkerN
RichesD
EgholmM
ToddJA
2009 Rare variants of IFIH1, a gene implicated in antiviral responses, protect against type 1 diabetes. Science 324 387 389
16. PritchardJK
2001 Are rare variants responsible for susceptibility to common diseases? Am J Hum Genet 69 124 137
17. PritchardJK
CoxNJ
2002 The allelic architecture of human disease genes: common diseaseÐcommon variant… or not? Hum Mol Genet 11 2417 2423
18. MardisER
2008 The impact of next-generation sequencing technology on genetics. Trends Genet 24 133 141
19. ShendureJ
JiH
2008 Next-generation DNA sequencing. Nat Biotechnol 26 1135 1145
20. TuckerT
MarraM
FriedmanJM
2009 Massively parallel sequencing: the next big thing in genetic medicine. Am J Hum Genet 85 142 154
21. MetzkerML
2010 Sequencing technologies - the next generation. Nat Rev Genet 11 31 46
22. MorrisAP
ZegginiE
2009 An evaluation of statistical approaches to rare variant analysis in genetic association studies. Genet Epidemiol 34 188 193
23. LiB
LealSM
2008 Methods for detecting associations with rare variants for common diseases: application to analysis of sequence data. Am J Hum Genet 83 311 321
24. MadsenBE
BrowningSR
2009 A groupwise association test for rare mutations using a weighted sum statistic. PLoS Genet 5 e1000384 doi:10.1371/journal.pgen.1000384
25. PriceAL
KryukovGV
de BakkerPI
PurcellSM
StaplesJ
WeiLJ
SunyaevSR
2010 Pooled association tests for rare variants in exon-resequencing studies. Am J Hum Genet 86 832 838
26. NgSB
BuckinghamKJ
LeeC
BighamAW
TaborHK
2009 Exome sequencing identifies the cause of a mendelian disorder. Nat Genet 42 30 35
27. LiangL
ZoellnerS
AbecasisGR
2007 GENOME: a rapid coalescent-based whole genome simulator. Bioinformatics 23 1565 1567
28. WrightS
1949 Adaptation and selection. Genetics, Paleontology, and Evolution. Princeton Univ Press 365 389
Štítky
Genetika Reprodukčná medicínaČlánok vyšiel v časopise
PLOS Genetics
2011 Číslo 2
- Je „freeze-all“ pro všechny? Odborníci na fertilitu diskutovali na virtuálním summitu
- Gynekologové a odborníci na reprodukční medicínu se sejdou na prvním virtuálním summitu
Najčítanejšie v tomto čísle
- Meta-Analysis of Genome-Wide Association Studies in Celiac Disease and Rheumatoid Arthritis Identifies Fourteen Non-HLA Shared Loci
- MiRNA Control of Vegetative Phase Change in Trees
- The Cardiac Transcription Network Modulated by Gata4, Mef2a, Nkx2.5, Srf, Histone Modifications, and MicroRNAs
- Genome-Wide Transcript Profiling of Endosperm without Paternal Contribution Identifies Parent-of-Origin–Dependent Regulation of